Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells

Circulation

Volumn 97, Issue 8, 1998, Pages 721-728

  Takami, Shigeki ^a,b   Yamashita, Shizuya ^a,b   Kihara, Shinji ^a,b   Ishigami, Masato ^a,b   Takemura, Kaoru ^a,b   Kume, Noriaki ^a,b   Kita, Toru ^a,b   Matsuzawa, Yuji ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiovascular diseases; Cells; Growth substances; Leukocytes; Lipoproteins

Indexed keywords

APOLIPOPROTEIN; DITHIOTHREITOL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GROWTH PROMOTOR; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; BUERGER DISEASE; CARDIOVASCULAR DISEASE; CELL ADHESION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0032478089     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.721     Document Type: Article

References (46)

1. Berg, K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand. 1963;59:369-382.
2. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocirdial infarction. Atherosclerosis. 1981;38:51-61.
3. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men. BMJ. 1990;301:1248-1251.
4. Gaubau JW, Heideman C, Gotto AM Jr. Morrisett JD, Dahlen GH. Human plasma lipoprotein(a): structural properties. J Biol Chem. 1983;258:4582-4589.
5. Utermann G, Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 1983;154:357-361.
6. Fless GM, Rolih CA, Scanu AM. Heterogeneity of human plasma lipopro- tein(a). isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 1984;259:11470-11478.
7. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132-137.
8. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis. 1990;10:240-245.
9. Harpel PC, Gordun PR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989;80:3847-3851.
10. Gerrity RG, Naito HK, Richardson M, Schanz CJ. Dietary induced atherogenesis in swine. Am J Pathol. 1979;95:775-785.
11. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. Arteriosclerosis. 1984;4:323-340.
12. Joris I, Zand T, Nunnari JJ, Krolikoski FJ, Majno G. Studies on the pathogenesis of atherosclerosis. I: adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol. 1983;113:341-358.
13. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
14. Simmons D, Makgoba MW, Seed B. ICAM-1, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature. 1988;331:624-627.
15. Stauton DE, Marlin SU, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of immunoglobulin and integrin supergene families. Cell. 1988;52:925-933.
16. Bevilacqua M, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1 : an inducible adhesion receptor to neutrophils related to complement regulatory proteins and lectins. Science. 1989;243:1160-1165.
17. Besvilacqua M, Butcher E, Furie B, Gallatin M, Gimbrone M Jr, Harlan J, Kishimoto K, Lasky L, McEver R, Paulson J. Selectins: a family of adhesion receptors. Cell. 1991;67:233.
18. Osborn L, Hession C, Tizard R, Vassalio B, Luhowsky S, Chi-Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1: a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203-1211.
19. Rice GE, Munro JM, Bevilacqua MP. Induciblc cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/ CD18-independent adhesion mechanisms. J Exp Med. 1990;171:1369-1374.
20. Carlos T, Kovach N, Schwanz B, Rosa M, Newman B, Wayner E, Benjamin C, Osbom L, Lobb R, Harlan J. Human monocyte binds to two cytokine-induced adhesion ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular tell adhesion molccule-1. Blood. 1991;77:2260-2271.
21. Poston RN, Hascard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaque. Am J Pathol. 1992;140:665-673.
22. Takami S, Kubo M, Yamashita S, Kameda-Takemura K, Kawasaki T, Kanbayashi J, Nakamura Y, Yokoi Y, Ohnishi K, Matsuzawa Y. High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans. Atherosclerosis. 1995;112:253-260.
23. Fless GM, Sydney ML. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J Biol Chem. 1992;267:339-346.
24. Utermann G, Menzel HJ, Kraft HG, Uuba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)lipoprotein concentrations in plasma. J Clin Invest. 1987:80:458-465.
25. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
26. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines: regulation by pharmacologie agents and neutralizing antibodies. J Immunoll. 1988;141:1665-1669.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
28. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning. Laboratory Manual. 2nd ed. Cold Spring Harbor. NY: Cold Spring Harbor Laboratories: 1989.
29. Sporn MB, Roberts AB. The transforming factor-βs. In: Peptide growth factors I. New York, NY: Springer-Verlag: 1990.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
31. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976;15:212-216.
32. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
33. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
34. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984;81:3883-3887.
35. Model DW, DiCorleto PE, Chisolm CM III. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984;4:357-364.
36. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science. 1993;260:1655-1657.
37. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 1986;59:199-204.
38. Libby P, Hannson GK. Involvement of the immune system in human atherosclerosis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
39. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density- lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
40. Territo MC, Berliner JA, Almada L, Ramirez R. Fogelman AM. β-VLDL pretreatment of endothelial monolayers increases monocyte but not neutrophil adhesion. Arteriosclerosis. 1989;9:824-828.
41. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1149.
42. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Burtler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1380.
43. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis. J Biol Chem. 1991;266:2459-2465.
44. Bayne EK, Rupp EA, Limjuco G, Chin J, Schmidt JA. Immunohistochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med. 1986;163:1267-1280.
45. Chensue SW, Remick DG, Shmyr-Forsch C, Beals TF, Kunkel SL. Immunohistochemical demonstration of cytoplasmic and membrane associated tumor necrosis factor in murino macrophages. Am J Pathol. 1988; 133:564-572.
46. Doukas J, Pober JS. Lymphocyte-mediated activation of cultured endothelial cells. J Immunol. 1990;145:1088-1098